With Another Phase III Trial, BNAC Solidifies Imaging Expertise

Monday, June 5th, 2017

UB’s Buffalo Neuroimaging Analysis Center (BNAC) played a pivotal role in a phase III clinical trial of the first transcatheter cerebral embolic protection (TCEP) device to obtain marketing clearance by the Food and Drug Administration.

Don't Dismiss CCVSI Yet, Expert Says

Monday, June 10th, 2013